Basil Biotech (CEO Park Jong-moon) announced that it will participate in ‘BIO KOREA 5’ held at COEX, Seoul for three days from May 10 (Wed) to 12 (Fri).
Established in 2017, Basil Biotech is a company specializing in mass spectrometry-based OMICS analysis and has global analysis technology know-how based on numerous R&D and joint research for more than 10 years. In addition, it is equipped with high-performance liquid chromatography equipment, high-resolution mass spectrometry equipment, and a sample automation system capable of processing hundreds of samples at a time, sharing equipment with a number of national and public laboratories and partner companies. We provide high-quality research services. In particular, Basil Biotech explained that it is recognized as an unrivaled company in the field of proteomic analysis, metabolomic analysis, geologic analysis, glycomic analysis, and the development of automated systems for sample purification and separation methods, and is increasing its awareness.
Mass spectrometry, a core technology of Basil Biotech, is characterized by its infinite application fields and its ability to be applied in various fields in the healthcare field. Currently, there are five OMICS services: proteomics, metabolomics, lipidomics, glycomics, and peptidomics analysis services. In addition, multi-omics analysis that analyzes some of these five types in multiplex is also available upon request. A service is also provided to subdivide tissue samples into equal amounts after the cyro-prep process for multi-omics analysis, enhancing user convenience.
In the case of clinical blood samples, it was also emphasized that the company provides a separate sample preparation service that can minimize the difference between sample analysis results using automated equipment. Each analysis service includes bioinformatics analysis, allowing researchers to process data in the desired format, and provides results and services through continuous communication with customers.
Park Jong-moon, CEO of Basil Biotech, established the company with more than 10 years of research experience and proficiency in the field of mass spectrometry. In particular, since it has been developed around foreign CRO companies, it has developed its own mass spectrometry system to localize it and provide it as a service.
Regarding this, an official from Basil Biotech said, “The proteomics analysis service industry is growing by 15% every year worldwide, but in Korea, it has grown mainly in the US and Europe due to technological limitations. Through these case studies in the US and Europe, we applied a Korean-style multi-omics analysis service model,” he said. We provide analysis services. In addition, although lipidomics and glycomics analysis services are very important fields for identifying and analyzing a wide range of biological processes, few companies provide services in Korea, but the company provides both of the above services. ”he explained.
“By establishing a corporate affiliated research institute in 2022, we are actively pursuing R&D. We are working hard on research to prepare guidelines for evaluating the taste of cultured meat, which is emerging as a food for the future, with mass spectrometry. “In particular, we are in the process of developing a diagnostic kit that non-expert patients can purchase at pharmacies and hospitals and self-diagnose periodontitis, which is emerging as a social problem due to the increase in the elderly population. We plan to launch a new product in the second half of next year at the earliest.”
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th this year, is hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. Since 2006, BIO KOREA, which has been striving to promote the global status and continuous growth of the Korean health industry, has been strengthening its position as Korea’s representative bio-health international convention with world-renowned scholars and business experts participating every year. BIO KOREA 2023, together with domestic and foreign companies related to the health industry such as bio, pharmaceuticals, medical devices, cosmetics, and food, as well as companies and institutions of interest such as consulting, academia, and related organizations, offers various programs such as conferences, business partnering, exhibitions, and invest fairs. It goes on.